206 related articles for article (PubMed ID: 30001234)
21. Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression.
Yu TH; Yuan RH; Chen YL; Yang WC; Hsu HC; Jeng YM
Mod Pathol; 2011 Jun; 24(6):810-9. PubMed ID: 21423153
[TBL] [Abstract][Full Text] [Related]
22. Thyroid-Like Cholangiocarcinoma: Histopathological, Immunohistochemical, In-Situ Hybridization and Molecular Studies on an Uncommon Emerging Entity.
Hissong E; Chiu K; Park H; Solomon J; Song W; Jessurun J
Int J Surg Pathol; 2021 Dec; 29(8):920-925. PubMed ID: 33939475
[TBL] [Abstract][Full Text] [Related]
23. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.
Tsai JH; Huang WC; Kuo KT; Yuan RH; Chen YL; Jeng YM
Histopathology; 2012 Dec; 61(6):1106-16. PubMed ID: 22882148
[TBL] [Abstract][Full Text] [Related]
24. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
25. Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors?
Ercolani G; Dazzi A; Giovinazzo F; Ruzzenente A; Bassi C; Guglielmi A; Scarpa A; D'Errico A; Pinna AD
Eur J Surg Oncol; 2015 Sep; 41(9):1162-9. PubMed ID: 26095704
[TBL] [Abstract][Full Text] [Related]
26. Prevalence, Risk Factors, and Survival of Patients with Intrahepatic Cholangiocarcinoma.
Chinchilla-López P; Aguilar-Olivos NE; García-Gómez J; Hernández-Alejandro KK; Chablé-Montero F; Motola-Kuba D; Patel T; Méndez-Sánchez N
Ann Hepatol; 2017; 16(4):565-568. PubMed ID: 28611259
[TBL] [Abstract][Full Text] [Related]
27. MDM2 Amplification in Intrahepatic Cholangiocarcinomas: Its Relationship With Large-Duct Type Morphology and Uncommon KRAS Mutations.
Kim SJ; Akita M; Sung YN; Fujikura K; Lee JH; Hwang S; Yu E; Otani K; Hong SM; Zen Y
Am J Surg Pathol; 2018 Apr; 42(4):512-521. PubMed ID: 29309301
[TBL] [Abstract][Full Text] [Related]
28. [Gallbladder and bile duct carcinoma. Biology and pathology].
Tannapfel A; Wittekind C
Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
[TBL] [Abstract][Full Text] [Related]
29. Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.
Haas S; Gütgemann I; Wolff M; Fischer HP
Am J Surg Pathol; 2007 Jun; 31(6):902-6. PubMed ID: 17527078
[TBL] [Abstract][Full Text] [Related]
30. Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: correlations with cholangiocarcinoma aggressiveness.
Vasuri F; Rocchi L; Degiovanni A; Giunchi F; Brandi G; Treré D; Montanaro L; D'Errico-Grigioni A
Histopathology; 2015 Jan; 66(2):244-51. PubMed ID: 25367684
[TBL] [Abstract][Full Text] [Related]
31. Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma.
Gardini A; Corti B; Fiorentino M; Altimari A; Ercolani G; Grazi GL; Pinna AD; Grigioni WF; D'Errico Grigioni A
Dig Liver Dis; 2005 Apr; 37(4):269-74. PubMed ID: 15788211
[TBL] [Abstract][Full Text] [Related]
32. A Subset of Intrahepatic Cholangiocarcinomas Express Albumin RNA as Detected by In Situ Hybridization.
Avadhani V; Cohen C; Siddiqui MT; Krasinskas A
Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):175-179. PubMed ID: 33181516
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis.
Huang Q; Liu L; Liu CH; You H; Shao F; Xie F; Lin XS; Hu SY; Zhang CH
Asian Pac J Cancer Prev; 2013; 14(2):829-34. PubMed ID: 23621247
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type.
Aishima S; Oda Y
J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):94-100. PubMed ID: 25181580
[TBL] [Abstract][Full Text] [Related]
35. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
[TBL] [Abstract][Full Text] [Related]
36. Cholangiocarcinoma.
Krasinskas AM
Surg Pathol Clin; 2018 Jun; 11(2):403-429. PubMed ID: 29751883
[TBL] [Abstract][Full Text] [Related]
37. Genetic and molecular abnormalities in cholangiocarcinogenesis.
Hassid VJ; Orlando FA; Awad ZT; Tan D; Khoury T; Ahmed BH; Alrawi SJ
Anticancer Res; 2009 Apr; 29(4):1151-6. PubMed ID: 19414358
[TBL] [Abstract][Full Text] [Related]
38. Cholangiocarcinoma: new insights into disease pathogenesis and biology.
Braconi C; Patel T
Infect Dis Clin North Am; 2010 Dec; 24(4):871-84, vii. PubMed ID: 20937455
[TBL] [Abstract][Full Text] [Related]
39. Spread of hilar cholangiocarcinomas via peribiliary gland network: a hither-to-unrecognized route of periductal infiltration.
Sato H; Nakanuma Y; Kozaka K; Sato Y; Ikeda H
Int J Clin Exp Pathol; 2013; 6(2):318-22. PubMed ID: 23330019
[TBL] [Abstract][Full Text] [Related]
40. CA9 overexpression is an independent favorable prognostic marker in intrahepatic cholangiocarcinoma.
Gu M
Int J Clin Exp Pathol; 2015; 8(1):862-6. PubMed ID: 25755787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
